{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T09:59:39Z","timestamp":1780480779507,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmech.2021.113802","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T22:50:39Z","timestamp":1630709439000},"page":"113802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Vincristine-doxorubicin co-loaded artificial low-density lipoproteins towards solid tumours"],"prefix":"10.1016","volume":"226","author":[{"given":"Mingyuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingguo","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113802_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biomaterials.2017.05.034","article-title":"Revisiting the value of competition assays in folate receptor-mediated drug delivery","volume":"138","author":"Jones","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2021.113802_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4251\/wjgo.v10.i7.159","article-title":"HER2 inhibition in gastro-oesophageal cancer: a review drawing on lessons learned from breast cancer, World","volume":"10","author":"Lote","year":"2018","journal-title":"J.\u00a0Gastrointest. Oncol."},{"key":"10.1016\/j.ejmech.2021.113802_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/10717544.2018.1435747","article-title":"Transferrin and octaarginine modified dual-functional liposomes with improved cancer cell targeting and enhanced intracellular delivery for the treatment of ovarian cancer","volume":"25","author":"Deshpande","year":"2018","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejmech.2021.113802_bib4","doi-asserted-by":"crossref","first-page":"19263","DOI":"10.1074\/jbc.RA118.002894","article-title":"Up-regulation of the kinase gene SGK1 by progesterone activates the AP-1\u2013NDRG1 axis in both PR-positive and -negative breast cancer cells","volume":"293","author":"Godbole","year":"2018","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113802_bib5","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/cei.13090","article-title":"Immune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1","volume":"192","author":"Hoeres","year":"2018","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.ejmech.2021.113802_bib6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/acs.analchem.5b04091","article-title":"Low-density lipoprotein sensor based on molecularly imprinted polymer","volume":"88","author":"Chunta","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2021.113802_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117013","article-title":"Low density lipoprotein receptor (LDLR)-targeted lipid nanoparticles for the delivery of sorafenib and Dihydroartemisinin in liver cancers","volume":"239","author":"Wang","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.ejmech.2021.113802_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1101\/gad.316646.118","article-title":"Signaling pathways and steroid receptors modulating estrogen receptor \u03b1 function in breast cancer","volume":"32","author":"Siersb\u00e6k","year":"2018","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2021.113802_bib9","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2147\/DDDT.S152420","article-title":"Lymphoma-targeted treatment using a folic acid-decorated vincristine-loaded drug delivery system","volume":"12","author":"Qiu","year":"2018","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.ejmech.2021.113802_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ijpharm.2018.12.023","article-title":"RGD-modified PEGylated paclitaxel nanocrystals with enhanced stability and tumour-targeting capability","volume":"556","author":"Huang","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2021.113802_bib11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jconrel.2019.02.043","article-title":"Theranostic iRGD peptide containing cisplatin prodrug: dual-cargo tumour penetration for improved imaging and therapy","volume":"300","author":"Cho","year":"2019","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2021.113802_bib12","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.omtn.2018.09.002","article-title":"An efficient bivalent cyclic RGD-PIK3CB siRNA conjugate for specific targeted therapy against glioblastoma in\u00a0vitro and in\u00a0vivo","volume":"13","author":"Cen","year":"2018","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2021.113802_bib13","doi-asserted-by":"crossref","first-page":"3967","DOI":"10.1038\/s41388-018-0213-4","article-title":"NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumour vasculature arrests cancer cell growth","volume":"37","author":"Seidi","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2021.113802_bib14","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.2147\/IJN.S176012","article-title":"Transferrin and folic acid co-modified bufalin-loaded nanoliposomes: preparation, characterization, and application in anticancer activity","volume":"13","author":"Chen","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2021.113802_bib15","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s11095-016-1924-2","article-title":"Thermo-Sensitive liposome co-loaded of vincristine and doxorubicin based on their similar physicochemical properties had synergism on tumour treatment","volume":"33","author":"Li","year":"2016","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.ejmech.2021.113802_bib16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2019.12.023","article-title":"The role of liposomes in clinical nanomedicine development. What now? Now what?","volume":"318","author":"Crommelin","year":"2020","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2021.113802_bib17","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1021\/acs.jmedchem.5b01534","article-title":"Enhanced sphingomyelinase activity contributes to the apoptotic capacity of electronegative low-density lipoprotein","volume":"59","author":"Ke","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113802_bib18","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1021\/nl1041947","article-title":"Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery","volume":"11","author":"McMahon","year":"2011","journal-title":"Nano Lett."},{"key":"10.1016\/j.ejmech.2021.113802_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00280-019-03884-5","article-title":"Aspects of vincristine-induced neuropathy in hematologic malignancies: a systematic review","volume":"84","author":"Madsen","year":"2019","journal-title":"Canc. Chemother. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113802_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijpharm.2011.05.013","article-title":"Development and characteristics of temperature-sensitive liposomes for vinorelbine bitartrate","volume":"414","author":"Zhang","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejmech.2021.113802_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0168-3659(02)00323-1","article-title":"A\u00a0lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration","volume":"86","author":"Lundberg","year":"2003","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2021.113802_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/0021-9797(88)90321-9","article-title":"Protein adsorption on polymeric biomaterials. I. Adsorptive isotherms","volume":"124","author":"Young","year":"1988","journal-title":"J.\u00a0Colloid Interface Sci."},{"key":"10.1016\/j.ejmech.2021.113802_bib23","first-page":"8019","article-title":"The role of VEGF in the diagnosis and treatment of malignant pleural effusion in patients with non-small cell lung cancer","volume":"17","author":"Chen","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ejmech.2021.113802_bib24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1124\/mol.117.111385","article-title":"Endoxifen, 4-hydroxytamoxifen and an estrogenic derivative modulate estrogen ReceptorComplex mediated apoptosis in breast cancer","volume":"94","author":"Maximov","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113802_bib25","article-title":"Cell membrane-coated nanosized active targeted drug delivery systems homing to tumour cells: a review","volume":"106","author":"He","year":"2020","journal-title":"Math. Sci. Eng."},{"key":"10.1016\/j.ejmech.2021.113802_bib26","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1016\/j.biomaterials.2014.01.076","article-title":"PEGylated liposomes with NGR ligand and heat-activable cellpenetrating peptide doxorubicin conjugate for tumour-specific therapy","volume":"35","author":"Yang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejmech.2021.113802_bib27","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1016\/j.jconrel.2017.03.200","article-title":"Thermo-responsive magnetic liposomes for hyperthermia-triggered local drug delivery","volume":"259","author":"Dai","year":"2017","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2021.113802_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.apsb.2018.10.005","article-title":"Emerging transporter -targeted nanoparticulate drug delivery systems, Acta","volume":"9","author":"Su","year":"2019","journal-title":"Der Pharm. Sin. B."},{"key":"10.1016\/j.ejmech.2021.113802_bib29","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","article-title":"Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer","volume":"98","author":"Kalyane","year":"2019","journal-title":"Math. Sci. Eng."},{"key":"10.1016\/j.ejmech.2021.113802_bib30","first-page":"6327","article-title":"Molecular mechanisms and anticancer therapeutic strategies in vasculogenic mimicry","volume":"10","author":"Zhang","year":"2019","journal-title":"J.\u00a0Canc."},{"key":"10.1016\/j.ejmech.2021.113802_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006751","article-title":"Modelling the transport of fluid through heterogeneous, whole tumours in silico","volume":"15","author":"Sweeney","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ejmech.2021.113802_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumour targeting via EPR: strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejmech.2021.113802_bib33","first-page":"29","article-title":"Development and evaluation of novel tumour-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in\u00a0vitro and in\u00a0vivo","volume":"37","author":"Yao","year":"2018","journal-title":"J.\u00a0Exp. Clin. Canc. Res."},{"key":"10.1016\/j.ejmech.2021.113802_bib34","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jconrel.2007.09.007","article-title":"Synthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiforme","volume":"124","author":"Nikanjam","year":"2007","journal-title":"J.\u00a0Contr. Release"},{"key":"10.1016\/j.ejmech.2021.113802_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2119\/molmed.2017.00011","article-title":"Repurposing mebendazole as a replacement for vincristine for the treatment of brain tumours","volume":"23","author":"Witt","year":"2017","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejmech.2021.113802_bib36","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.actbio.2019.06.051","article-title":"Low density lipoprotein-inspired nanostructured lipid nanoparticles containing pro-doxorubicin to enhance tumour-targeted therapeutic efficiency","volume":"96","author":"Li","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejmech.2021.113802_bib37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clml.2013.09.009","article-title":"Phase II study of vincristine sulfate liposome injection (Marqibo) and rituximab for patients with relapsed and refractory diffuse large B-cell lymphoma or Mantle cell lymphoma in need of palliative therapy","volume":"14","author":"Kaplan","year":"2014","journal-title":"Clin. Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.ejmech.2021.113802_bib38","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/vms3.119","article-title":"Intratumoural recombinant human interferon alpha-2a and vincristine combination therapy in canine transmissible venereal tumour","volume":"4","author":"Kanca","year":"2018","journal-title":"Vet. Med. Sci."},{"key":"10.1016\/j.ejmech.2021.113802_bib39","first-page":"705","article-title":"Quantification of vincristine sulfate in dog plasma by HPLC-MS\/MS and pharmacokinetics of vincristine sulfate thermosensitive liposomes in dogs","volume":"50","author":"Li","year":"2015","journal-title":"Inst. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2021.113802_bib40","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.2147\/IJN.S205276","article-title":"Development of a stable single-vial liposomal formulation for vincristine","volume":"14","author":"Mao","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejmech.2021.113802_bib41","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.3390\/ijms19092790","article-title":"Nanoparticles with high-surface negative-charge density disturb the metabolism of low-density lipoprotein in cells","volume":"19","author":"Bai","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.113802_bib42","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20176650","article-title":"Low density lipoprotein modified silica nanoparticles loaded with docetaxel and thalidomide for effective chemotherapy of liver cancer","volume":"51","author":"Ao","year":"2018","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"3","key":"10.1016\/j.ejmech.2021.113802_bib43","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20177090","article-title":"Lipid core nanoparticles resembling low-density lipoprotein and regression of atherosclerotic lesions: effects of particle size","volume":"51","author":"Freitas","year":"2018","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.ejmech.2021.113802_bib44","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ijpharm.2015.05.073","article-title":"A\u00a0novel drug-polyethylene glycol liquid compound method to prepare 10-hydroxycamptothecin loaded human serum albumin nanoparticle","volume":"490","author":"Yang","year":"2015","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421006516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421006516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:32:31Z","timestamp":1759329151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421006516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":44,"alternative-id":["S0223523421006516"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113802","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vincristine-doxorubicin co-loaded artificial low-density lipoproteins towards solid tumours","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113802"}}